Human Longevity, Inc. Launches Pilot Program, Health Nucleus X

HNX focuses on core testing areas of whole genome sequencing and advanced whole body, 3T, non-contrast MRI and takes about three hours. The pilot is being offered in the Health Nucleus facility in La Jolla, California from May 1 through June 30, 2017 for an introductory price of $7,500. The company expects to open free standing HNX facilities in other cities.

The company also offers its more comprehensive Health Nucleus Platinum program which is a full eight-hour day of health testing that includes the two modalities from HNX along with others such as CT scans, echocardiogram, EKG, and a more complete battery of metabolic and lab testing. To date 570 people have participated in the HN Platinum experience with nearly 40% having had significant findings which were found at an early stage. Health Nucleus and HNX both provide a new approach to provide clients with personalized health insights into cancer, neurological, metabolic and cardiovascular disease risk.

"Building on the success and important health findings from our Health Nucleus Platinum experience, we are pleased to pilot Health Nucleus X which we believe will enable more people to experience the health insights that come from this advanced testing," said Cynthia Collins, CEO, HLI. "Our aim with the Health Nucleus and HNX is to give individuals and their physicians the data to create integrated, personalized and proactive health plans for their future."

Specifically, the HNX experience includes:

• Advanced whole body and brain MRI scan
• Whole genome sequence analysis
• A few specific laboratory tests
• An in-depth report with full review of the results
• Microbiome test (included for an additional $500)

Health Nucleus Platinum and HNX give clients and their physicians access to the latest MRI technology and use advanced protocols with review by expert clinicians all of which is not routinely available anywhere else. The Health Nucleus team of clinicians and scientists review individual findings and integrate these with the genome sequencing to provide personalized health insights. The whole genome testing can also give insights into which pharmaceuticals may work better for individuals, carrier status for family planning decisions, along with ancestry and personal traits.

About Human Longevity, Inc™

Human Longevity, Inc. (HLI) is the genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived. HLI combines the largest database of genomic and phenotypic data with machine learning to drive discoveries and revolutionize the practice of medicine. HLI's business areas include the HLI Health Nucleus, a genomic powered clinical research center which uses whole genome sequence analysis, advanced clinical imaging and innovative machine learning, along with curated personal health information, to deliver the most complete picture of individual health; HLIQ Whole Genome and HLIQ Oncology. For more information, please visit http://www.humanlongevity.com or http://www.healthnucleus.com.

SOURCE Human Longevity, Inc.

Related Links

http://www.healthnucleus.com